PURE BIOSCIENCE, INC. (PURE) › Operating IncomePURE BIOSCIENCE, INC. (PURE) — Operating IncomeAnnual figures by fiscal year, from SEC filings.2011: -$8.37M2012: -$8.75M2013: -$7.34M2014: -$11.90M2015: -$7.64M2016: -$7.06M2017: -$6.01M2018: -$7.04M2019: -$5.59M2020: $4.0K2021: -$2.31M2022: -$3.72M2023: -$3.94M2024: -$3.19M2025: -$2.27M-$2.27M2011Operating Income (USD)2025Fiscal YearOperating IncomeChange YoY2025-$2.27M+28.8%2024-$3.19M+19.1%2023-$3.94M-5.9%2022-$3.72M-61.1%2021-$2.31M-57875.0%2020$4.0K+100.1%2019-$5.59M+20.6%2018-$7.04M-17.2%2017-$6.01M+14.9%2016-$7.06M+7.6%2015-$7.64M+35.8%2014-$11.90M-62.2%2013-$7.34M+16.2%2012-$8.75M-4.6%2011-$8.37M—Other metrics: RevenueCost of RevenueGross ProfitNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowCapital ExpendituresShares OutstandingDividends Per Share